08 Aug SAHPRA website now has a revamped navigation
Pexels via Pixabay...
News & Updates
06 Aug SAHPRA educates, informs during SAAPI Conference 2022
Johannesburg, 06 August 2022 - The South African Health Products Regulatory Authority (SAHPRA) was invited to speak at this year’s South African Association of Pharmacists in Industry (SAAPI) Conference during 03-05 August 2022 sharing vital information across core functional areas of the organisation. SAHPRA was...
04 Aug Update on COVID-19 Vaccine Janssen – Guillain-Barré syndrome
04 August 2022 On 31 March 2021, SAHPRA approved the use of the COVID-19 Vaccine Janssen for individuals 18 years of age and older as a single primary vaccination dose. COVID-19 Vaccine Janssen was later approved as a single booster dose given at least two months...
22 Jul SAHPRA CEO wins Management accolade at “Science Oscars”
Pretoria, 22 July 2022 - SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, clinched a Management Award at last night's 24th National Science and Technology Forum (NSTF) Awards, that recognises outstanding contributions to science, engineering and technology (SET), and innovation. According to NSTF, Dr Semete-Makokotlela earned her accolade as...
21 Jul SAHPRA’s Radiation Control Unit delivers Compliance Workshop @ NICD
21 July 2022 Johannesburg – The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA) delivered an informative Compliance Workshop at the National Institute of Communicable Diseases (NICD) on Thursday, 21 July 2022. Radiation Control Manager, Kgomotso Tlhapi, led the workshop during the first...
20 Jul SAHPRA clarifies process for importation of medicines
Embargo: Immediate release Pretoria, 20 July 2022 – The South African Health Products Regulatory Authority (SAHPRA) has noted the numerous media articles on the statement made by Minister Sisulu, having secured medicine for the late Jessie Duarte. To this effect, SAHPRA is looking into the reports...
19 Jul SAHPRA & UK’s Department for International Trade sign MOU
19 July 2022 Johannesburg – The South African Health Products Regulatory Authority (SAHPRA) and the UK’s Department for International Trade (DIT) signed a Memorandum of Understanding (MOU) today, in Sandton. The key objective of the MOU is to demonstrate the countries’ intentions to collaborate in good faith,...
28 Jun Health Product literacy top of mind as SAHPRA announces online medicines directory
28 June 2022 The South African Health Products Authority (SAHPRA) is pleased to announce the launch of an Over the Counter (OTC) Online Medicines’ Directory for South African consumers and healthcare professionals. The domain name is https://medsinfo.sahpra.org.za and the portal is available on the SAHPRA website. The...
28 Jun SAHPRA’s MOU with SANAS extended
28 June 2022 Pretoria – The South African Health Products Regulatory Authority (SAHPRA) initially signed a Memorandum of Understanding (MOU) with the South African National Accreditation System (SANAS) in 2017 and this will now be extended in 2022. This MOU will now also incorporate the following activities...
24 Jun SAHPRA registers the COVID-19 vaccine, Coronavac
Embargo: Immediate release Pretoria, 24 June 2022 – The South African Health Products and Regulatory Authority (SAHPRA) registered the COVID-19 vaccine, Coronavac, on 14 June 2022, with conditions. The registration was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101 of...